Daloyon, Helen S.
HRN: 22-28-84 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2022
CEFTRIAXONE 1G (VIAL)
12/04/2022
12/10/2022
IV
1g
Q12
T/C Complicated UTI
Waiting Final Action